Company: Tailstorm Health Inc., doing business as Medivant Health Type: Compounding pharmacy and FDA-registered outsourcing facilityWarning Letter Date: April 8, 2025FDA Department issuing Warning: Center for Drug Evaluation and Research (CDER)Facility Location: Phoenix, ArizonaInspection Dates: September 24, 2024, to October 10, 2024
Wegovy if prescribed for cardiovascular risk reduction in adults with obesity/overweight + established heart disease
Evidence on benefits beyond two years was more limited
Most clinical studies show that meaningful changes in gut microbiome composition require 2 to 6 weeks of consistent supplementation
ATTAIN-1: Eli Lilly's orforglipron 36 mg achieved 12.4% loss (27.3 lbs) at 72 weeks
We offer compounded semaglutide, prepared per-patient by a state-licensed U.S